Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

Condition:   Chikungunya Virus Infection Interventions:   Biological: VLA1553;   Biological: Placebo Sponsor:   Valneva Austria GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials